257 related articles for article (PubMed ID: 9478071)
1. Psychiatric illness in mental retardation: an update on pharmacotherapy.
Masi G; Luccherino L
Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric illness in mentally retarded adolescents: clinical features.
Masi G
Adolescence; 1998; 33(130):425-34. PubMed ID: 9706328
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacotherapy of patients with mental retardation during psychiatric hospitalization].
Bobińska K; Florkowski A; Smigielski J; Kryszkowski W; Gałecki P
Pol Merkur Lekarski; 2009 Nov; 27(161):381-7. PubMed ID: 19999801
[TBL] [Abstract][Full Text] [Related]
4. [Use of psychotropic drugs in children, adolescents and subjects with intellectual disability: a review].
Lazzeretti L; Pracucci C; Benni L; Godini L; Talamba GA; Faravelli C
Riv Psichiatr; 2011; 46(1):1-17. PubMed ID: 21446107
[TBL] [Abstract][Full Text] [Related]
5. [Psychotropic medicines to patients with mental retardation].
Bygdnes AM; Kristiansen A
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
[TBL] [Abstract][Full Text] [Related]
6. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
Näslund I
Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
[No Abstract] [Full Text] [Related]
7. Rational use and rationale for use: psychiatric medication at an Argentine institution for intellectual disability.
de Menil V; Cohen A
Transcult Psychiatry; 2009 Dec; 46(4):651-71. PubMed ID: 20028682
[TBL] [Abstract][Full Text] [Related]
8. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
9. The use of risperidone among individuals with mental retardation: clinically supported or not?
Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
[TBL] [Abstract][Full Text] [Related]
10. Clozapine, mental retardation, and severe psychiatric illness: clinical response in the first year.
Rubin M; Langa A
Harv Rev Psychiatry; 1995; 2(5):293-4. PubMed ID: 9384915
[No Abstract] [Full Text] [Related]
11. [Characteristics of mental disorders in psychiatric patients with mental retardation--preliminary communication].
Bobińska K; Florkowski A; Gałecki P
Pol Merkur Lekarski; 2008; 25 Suppl 1():8-12. PubMed ID: 19025040
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
[TBL] [Abstract][Full Text] [Related]
13. [Considerations of psychopathology in mental retardation].
Masi G
Minerva Psichiatr; 1994 Jun; 35(2):81-92. PubMed ID: 7934739
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
Madrid AL; State MW; King BH
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
[TBL] [Abstract][Full Text] [Related]
15. The use of clozapine among individuals with intellectual disability: a review.
Singh AN; Matson JL; Hill BD; Pella RD; Cooper CL; Adkins AD
Res Dev Disabil; 2010; 31(6):1135-41. PubMed ID: 20692809
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
Holden B; Gitlesen JP
Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
Kanner AM; Gidal BE
Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
[TBL] [Abstract][Full Text] [Related]
18. Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription.
de Kuijper G; Hoekstra P; Visser F; Scholte FA; Penning C; Evenhuis H
J Intellect Disabil Res; 2010 Jul; 54(7):659-67. PubMed ID: 20426795
[TBL] [Abstract][Full Text] [Related]
19. Current concepts. Psychopharmacology in children.
Biederman J; Jellinek MS
N Engl J Med; 1984 Apr; 310(15):968-72. PubMed ID: 6142421
[No Abstract] [Full Text] [Related]
20. Pharmacological management of challenging behavior of individuals with intellectual disability.
McGillivray JA; McCabe MP
Res Dev Disabil; 2004; 25(6):523-37. PubMed ID: 15541630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
